404: May is Bladder Cancer Awareness Month 2021

Bladder cancer is the 6th most common cancer among men globally, and the 10th most common overall. Bladder Cancer Awareness Month is a time for those... read more

Public Health Providers Increase Commercial Use of Cxbladder

Pacific Edge are pleased to announce that two of New Zealand’s largest public healthcare providers – Counties Manukau Health and Waitematā District Health Board - are... read more

New Webinar: Alternative Strategies to Deliver Bladder Cancer Investigation During COVID-19 & Beyond

UroToday, a high profile news and education portal for urologists, have just released a new webinar focused on Cxbladder. In a discussion led by Neal Shore,... read more

Renowned US Oncologist & Author Recommends Cxbladder

Recognition and acceptance of Cxbladder continues to grow across the US medical community. In this video, renowned Oncologist and Author Dr Mark Scholz discusses the benefits... read more

Is Bladder Cancer Hereditary?

01 Is bladder cancer hereditary3 If one or more of your relatives has had bladder cancer, it's understandable to wonder if bladder cancer is hereditary. Population... read more

Managing Life After Bladder Cancer

01 Managing life after bladder cancer4 Completing your treatment and pushing bladder cancer back into remission is a reason to celebrate. You've made it through a... read more

Supporting a Friend with Bladder Cancer

When someone close receives a bladder cancer diagnosis, your first instinct will be to offer help. Your heart's in the right place there, however you may... read more

Healthy Aging for Older Adults

A healthy lifestyle can take many different forms as you age. From staying physically active and understanding your individual nutritional needs, to booking regular check-ups and... read more

Kaiser Permanente Approves Commercial use of Cxbladder

It gives us great pleasure to announce that Pacific Edge Limited and Kaiser Permanente have reached an agreement for the commercial use of our Cxbladder tests. Kaiser... read more

Pacific Edge Notified of Positive LCD Decision for Cxbladder in USA

Pacific Edge Limited (NZX: PEB), has been notified by Novitas1 that the LCD: Biomarkers for Oncology (L35396) provides coverage for Cxbladder, CPT codes 0012M (Cxbladder Detect)... read more